Skip to main content
. 2015 Oct 8;6(35):37782–37791. doi: 10.18632/oncotarget.5622

Figure 4. Systemic R11-p53C peptide administration inhibited T24 lung metastatic tumor growth.

Figure 4

A. R11-p53C peptide can be specifically detected in the lung metastatic lesions. Nude mice were intravenously injected with T24 cells for 14 days (n = 6/group). Tissues were collected 30 mins after R11-p53C and control peptides injected. I DMSO, II p53C, III R11-Con, IV R11-p53C. B–C. The BLI intensity was serially monitored (B) and quantified (C) in every group. D. The long-term survival of mice harboring lung metastatic burden after R11-p53C/control peptides/DMSO treatment.